Amicus Therapeutics, Inc. (FOLD): Price and Financial Metrics
FOLD Price/Volume Stats
| Current price | $6.22 | 52-week high | $12.65 |
| Prev. close | $6.05 | 52-week low | $5.51 |
| Day low | $6.04 | Volume | 4,186,200 |
| Day high | $6.25 | Avg. volume | 3,801,154 |
| 50-day MA | $6.20 | Dividend yield | N/A |
| 200-day MA | $8.75 | Market Cap | 1.92B |
FOLD Stock Price Chart Interactive Chart >
Amicus Therapeutics, Inc. (FOLD) Company Bio
Amicus Therapeutics is developing treatments for a broad range of human genetic diseases, with a focus on delivering new benefits to individuals with lysosomal storage disorders. The company was founded in 2002 and is based in Cranbury, New Jersey.
FOLD Price Returns
| 1-mo | 3.15% |
| 3-mo | -4.45% |
| 6-mo | -31.04% |
| 1-year | -39.67% |
| 3-year | -45.29% |
| 5-year | -59.95% |
| YTD | -33.97% |
| 2024 | -33.62% |
| 2023 | 16.22% |
| 2022 | 5.71% |
| 2021 | -49.98% |
| 2020 | 137.06% |
Continue Researching FOLD
Here are a few links from around the web to help you further your research on Amicus Therapeutics Inc's stock as an investment opportunity:Amicus Therapeutics Inc (FOLD) Stock Price | Nasdaq
Amicus Therapeutics Inc (FOLD) Stock Quote, History and News - Yahoo Finance
Amicus Therapeutics Inc (FOLD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...